



Advancing Science Across Industries
Guided by integrity, quality and collaboration to create meaningful scientific impact.
Ribosome Research Centre (RRC) is a global Contract Research Organization (CRO) providing comprehensive testing, research, and regulatory support services to the pharmaceutical, agrochemical, medical device, herbal, AYUSH, nutraceutical, cosmetic, and other product industries.
RRC operates as a one-stop solution for a broad spectrum of regulatory and non-regulatory studies, supporting clients throughout the product development and regulatory lifecycle—from early-stage research and characterization through pre-clinical safety assessment, analytical testing, and regulatory submissions.

Our Compliance
Advancing Science Across Industries
RRC is OECD GLP compliant and operates in accordance with US FDA Good Laboratory Practice (GLP) requirements under 21 CFR Part 58, supporting high-quality, traceable, scientifically sound, and regulatory-compliant studies intended for submission to regulatory authorities across global markets.

Guidelines We Follow
RRC conducts studies and testing in accordance with applicable international guidelines, regulatory requirements, standards, and pharmacopoeias, including OECD, US FDA, EPA, ISO, EC, JMAFF, EMA and other internationally recognized regulatory frameworks, as well as relevant Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), United States Pharmacopoeia (USP) and other applicable pharmacopoeial requirements.
Our Commitment
With integrated scientific expertise, modern laboratory infrastructure, experienced study personnel, and a strong quality and regulatory framework, RRC provides clients with a single platform for comprehensive product testing and safety evaluation.
Our objective is to deliver scientifically robust, quality-driven, timely, and globally acceptable data that supports product development, regulatory submissions, market authorization, and lifecycle management.


Stay connected with science
Stay Informed. Stay Ahead in Research.
Subscribe to receive the latest updates on pharmaceutical research, clinical and pre-clinical testing, medical device safety, regulatory developments, scientific insights and industry events from Ribosome Research Centre.









